Clinical Trial Update: Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of Venetoclax combined with a pediatric-inspired regimen for newly diagnosed B-cell acute lymphoblastic leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-like Acute Lymphoblastic Leukemia

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: City of Hope Medical Center | Conditions: B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING